Anitta Mahonen

Felszeghy, S; Gilbert, G; Koskela, A; Nieminen, P; Sironen, R; Pasonen-Seppänen, S; Sointu, E; Morton, D; Mahonen, A. 2019. As you sow, so shall you reap: Is there a "golden standard" to teach histology? MedEd publish 8 3: 1-5. 2019

Felszeghy, S; Pasonen-Seppänen, S; Koskela, A; Nieminen, P; Härkönen, K; Paldanius, KMA; Gabbouj, S; Ketola, K; Hiltunen, M; Lundin, M; Haapaniemi, T; Sointu, E; Bauman, EB; Gilbert, GE; Morton, D; Mahonen, A. 2019. Using online game-based platforms to improve student performance and engagement in histology teaching BMC Medical Education 19 1: 273. 2019

Soininen, Sonja; Eloranta, Aino-Maija; Viitasalo, Anna; Dion, Geneviève; Erkkilä, Arja; Sidoroff, Virpi; Lindi, Virpi; Mahonen, Anitta; Lakka, Timo A. 2018. Serum 25-Hydroxyvitamin D, Plasma Lipids, and Associated Gene Variants in Prepubertal Children JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 103 7: 2670-2679. 2018

Soininen, Sonja; Sidoroff, Virpi; Lindi, Virpi; Mahonen, Anitta; Kröger, Liisa; Kröger, Heikki; Jääskeläinen, Jarmo; Atalay, Mustafa; Laaksonen, David E; Laitinen, Tomi; Lakka, Timo A. 2018. Body fat mass, lean body mass and associated biomarkers as determinants of bone mineral density in children 6-8 years of age - The Physical Activity and Nutrition in Children (PANIC) study Bone 108: 106-114. 2018

Felszeghy Szabolcs, Pasonen-Seppänen Sanna, Koskela Ali, Mahonen Anitta. 2017. Student-focused virtual histology education: Do new scenarios and digital technology matter?. MedEdPublish 6 3: 40. 2017

Nieminen Petteri, Mahonen Anitta. 2017. Explaining science and pseudoscience to medical students with applications to interaction with patients. In: - (ed.) , AMEE 2017 Abstract Book. The Association for Medical Education in Europe (AMEE). s. 642. 2017

Soininen Sonja, Eloranta Aino-Maija, Lindi Virpi, Venäläinen Taisa, Zaproudina Nina, Mahonen Anitta, Lakka Timo A. 2016. Determinants of serum 25-hydroxyvitamin D concentration in Finnish children: the Physical Activity and Nutrition in Children (PANIC) study. BRITISH JOURNAL OF NUTRITION 115 6: 1080-1091. 2016

Leskinen Jarkko, Olkku Anu, Mahonen Anitta, Hynynen Kullervo. 2014. Nonuniform temperature rise in in vitro osteoblast ultrasound exposures with associated bioeffect. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING 61 3: 920-927. 2014

Pietilä M, Ryhänen S, Mahonen A, Palvimo J. 2013. Terveyden biotieteiden opiskelijoiden työelämäorientaation rakentaminen: Kaarniemi H, Luotsausta ja luovintaa. Publications of the University of Eastern Finland. General Series 12. 63-70. 2013

Olkku A, Leskinen JJ, Lammi MJ, Hynynen K & Mahonen A. 2010. Ultrasound-induced activation of Wnt signaling in human MG-63 osteoblastic cells BONE 47 2: 320-330. 2010

Olkku A, Mahonen A. 2009. Calreticulin mediated glucocorticoid receptor export is involved in ß-catenin translocation and Wnt signalling inhibition in human osteoblastic cells. BONE 44 4: 555-565. 2009

Korkalainen M, Kallio E, Olkku A, Nelo K, Ilvesaro J, Tuukkanen J, Mahonen A, Viluksela M. 2009. Dioxins interfere with differentation of osteoblasts and osteoclasts. BONE 44: 1134-1142. 2009

Leskinen JJ, Karjalainen HM, Olkku A, Hynynen K, Mahonen A, Lammi MJ. 2008. Genome-wide microarray analysis of MG-63 osteoblastic cells exposed to ultrasound. BIORHEOLOGY 45: 345-354. 2008

Olkku A, Mahonen A. 2008. Wnt and steroid pathways control glutamate signalling by regulating glutamine synthetase activity in osteoblastic cells. BONE 43: 483-493. 2008

Suurniemi M, Suominen H, Mahonen A, Alen M, Cheng S. 2007. Estrogen receptor alpha polymorphism modifies the association between childhood exercise and bone mass: follow-up study. PEDIATRIC EXERCISE SCIENCE 19 4: 444-58. 2007

Lammi MJ, Häyrinen J, Mahonen A. 2006. Proteomic analysis of cartilage- and bone-associated samples ELECTROPHORESIS 27: 2687-2701. 2006

Leskelä H-V, Olkku A, Lehtonen S, Mahonen A, Koivunen J, Turpeinen M, Uusitalo J, Pelkonen O, Kangas L, Selander K, Lehenkari P. 2006. Estrogen receptor alpha genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cell-derived osteoblasts. BONE 39: 1026-1034. 2006

Suuriniemi M, Kovanen V, Mahonen A, Alen M, Wang Q, Lyytikäinen A, Cheng S. 2006. COL1A1 Sp1 polymorphism associates with bone density in early puberty. BONE 39: 591-597. 2006

Tuppurainen M, Kröger H, Mahonen A, Kröger H. 2006. Periytyvätkö osteoporoosi ja luunmurtumat?. DUODECIM 122: 133-134. 2006

Eriksson A-L, Suuriniemi M, Mahonen A, Cheng S, Ohlsson C. 2005. The COMT val158met polymorphism is associated with early pubertal development, height and cortical bone mass in girls. PEDIATRIC RESEARCH 58 1: 71-77. 2005

Remes T, Väisänen SB, Mahonen A, Huuskonen J, Kröger H, Jurvelin JS, Rauramaa R. 2005. Bone mineral density, body height, and vitamin D receptor gene polymorphism in middle-aged men. Annals of Medicine 37: 383-392. 2005

Suuriniemi M, Mahonen A, Kovanen V, Alén M, Lyytikäinen A, Wang Q, Kröger H, Cheng S, Kröger H. 2004. Association between exercise and pubertal BMD is modulated by estrogen receptor alfa genotype JOURNAL OF BONE AND MINERAL RESEARCH 19 11: 1758-1765. 2004

Remes T, Väisänen SB, Mahonen A, Huuskonen J, Kröger H, Jurvelin JS, Penttilä IM, Rauramaa R, Kröger H. 2004. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men. BONE 35: 439-447. 2004

Olkku A, Bodine PVN, Linnala-Kankkunen A, Mahonen A. 2004. Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone. BONE 34: 320-329. 2004

Cheng S, Tylavsky F, Kröger H, Kärkkäinen M, Lyytikäinen A, Koistinen A, Mahonen A, Alen M, Halleen J, Väänänen K, Lamberg-Allardt C, Kröger H. 2003. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. AMERICAN JOURNAL OF CLINICAL NUTRITION 78: 485-492. 2003

Hiltunen MO, Ruuskanen M, Huuskonen J, Mähönen AJ, Ahonen M, Rutanen J, Kosma V-M, Mahonen A, Kröger H, Ylä-Herttuala S. 2003. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB JOURNAL 17: 1147-1149. 2003

Remes T, Väisänen SB, Mahonen A, Huuskonen J, Kröger H, Jurvelin JS, Penttilä IM, Rauramaa R. 2003. Aerobic exercise and bone mineral density in middle-aged Finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor alfa gene polymorphisms. BONE 32: 412-420. 2003

Ryhänen S, Jääskeläinen T, Mahonen A, Mäenpää P. 2003. Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein. BIOCHEMICAL PHARMACOLOGY 66: 495-504. 2003

Salmén T, Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH, Kröger H. 2003. Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women ANNALS OF MEDICINE (HELSINKI) 35: 282-288. 2003

Salmén T, Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH. 2003. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial. JOURNAL OF BONE AND MINERAL RESEARCH 18 2: 319-324. 2003

Suuriniemi M, Mahonen A, Kovanen V, Alen M, Cheng S. 2003. Relation of PvuII site polymorphism in the COL1A2 gene to the risk of fractures in prepubertal Finnish girls. PHYSIOLOGICAL GENOMICS (PRINTED AND ONLINE) 14 3: 217-24. 2003

Mäenpää PH, Jääskeläinen T, Ryhänen S, Mahonen A. 2002. Mechanism of action of superactive vitamin D analogs through regulated receptor degradation: Tsambaos D, Merk H, Modern Trends in Skin Pharmacology.Parissianos Medical Publications. 22-26. 2002

Salmén T, Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Partanen J, Mäenpää PH. 2002. Relation of estrogen receptor-alfa gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women. Annals of Medicine 34: 64-72. 2002

Salmén T, Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH. 2001. Estrogeenireseptori alfa-geenin polymorfia vaikuttaa hormonikorvaushoidon luustolle antamaan suojaan. DUODECIM 117: 738-739. 2001

Mäenpää PH, Väisänen S, Jääskeläinen T, Ryhänen S, Rouvinen J, Duchier C, Mahonen A. 2001. Vitamin D3 analogs (MC 1288, KH 1060, EB 1089, GS 1558, and CB 1093): studies on their mechanism of action STEROIDS (NEW YORK NY) 66: 223-225. 2001

Backström MC, Mahonen A, Ala-Houhala M, Sievänen H, Mäenpää P, Koivisto AM, Olkku A, Mäki R, Mäki M. 2001. Genetic determinants of bone mineral content in premature infants ARCHIVES OF DISEASE IN CHILDHOOD. FETAL AND NEONATAL EDITION (LONDON) 85: F214-F216. 2001

Jääskeläinen T, Ryhänen S, Mahonen A, DeLuca HF, Mäenpää PH. 2000. Mechanism of action of superactive vitamin D analogs through regulated receptor degradation. JOURNAL OF CELLULAR BIOCHEMISTRY 76: 548-558. 2000

Salmén T, Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH. 2000. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in finnish women: effect of hormone replacement therapy. JOURNAL OF BONE AND MINERAL RESEARCH 15 2: 315-321. 2000

Salmén T, Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH. 2000. Estrogeenireseptorigeenin polymorfia vaikuttaa luun menetyksen nopeuteen ja hormonikorvaushoidon tehoon menopaussin jälkeen. DUODECIM 116: 844. 2000

Salmén T, Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH. 2000. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alfa genotype in early postmenopausal women. JOURNAL OF BONE AND MINERAL RESEARCH 15 12: 2479-2486. 2000

Mahonen A, Jukkola A, Risteli L, Risteli J, Mäenpää PH. 1998. Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells. JOURNAL OF CELLULAR BIOCHEMISTRY 68: 151-163. 1998

Mahonen A, Jääskeläinen T, Mäenpää PH. 1996. A novel vitamin D analog with two double bonds in its side chain. A potent inducer of osteoblastic cell differentiation BIOCHEMICAL PHARMACOLOGY 51: 887-892. 1996

Ryhänen S, Mahonen A, Jääskeläinen T, Mäenpää PH. 1996. Synthetic 20-epi analogs of calcitriol are potent inducers of target-gene activation in osteoblastic cells. FEBS JOURNAL 238: 97-103. 1996

Kröger H, Mahonen A, Ryhänen S, Turunen A-M, Alhava E, Mäenpää P. 1995. Vitamin D receptor genotypes and bone mineral density. LANCET 345 8959: 1238. 1995

Mäenpää PH, Jääskeläinen T, Mahonen A. 1995. Effects of a new vitamin D analog, EB 1089, on osteoblastic cells. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 761: 349-350. 1995

Contact info

Organization

Email

Phone

Publications